Drupal.behaviors.print = function(context) {window.print();window.close();}>
Following Management Changes, Nanosphere Reports Revenue Growth, but Shortfalls in Dx Placements
February 26, 2013
Following Management Changes, Nanosphere Reports Revenue Growth, but Shortfalls in Dx Placements
By
Molika Ashford
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail
Molika Ashford
.
Related Stories
Raising $26.9M in Public Offering, Nanosphere Anticipates Growing Dx Portfolio
July 31, 2012 / BioArray News
In-Q-Tel Backs Quanterix to Expand Pathogen Detection for Defense Applications
January 10, 2012 / BioArray News
Nanosphere Releases Data on Gram-Positive Blood Culture Test Ahead of Anticipated FDA Approval
October 4, 2011 / BioArray News
CGI Pledges to Launch Two More Array Tests This Year after 'Busy' Q1
May 28, 2013 / BioArray News
Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News